Combined treatment: Impact of optimal psychotherapy and medication in bipolar disorder

Bipolar Disorders

Volumn 17, Issue 1, 2015, Pages 86-96

  Parikh, Sagar V ^a,b,c   Hawke, Lisa D ^a,b   Velyvis, Vytas ^a,d,e   Zaretsky, Ari ^b,f   Beaulieu, Serge ^g,h   Patelis Siotis, Irene ^i,j   Macqueen, Glenda ^k   Young, L Trevor ^b   Yatham, Lakshmi N ^l   Cervantes, Pablo ^g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d YORK UNIVERSITY   (Canada)

^e Adler International Learning   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k UNIVERSITY OF CALGARY   (Canada)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Bipolar disorder; Combined therapy; Course of illness; Depression; Hypomania; Mania; Subsyndromal symptoms

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; GABAPENTIN; MOOD STABILIZER; NEUROLEPTIC AGENT; TOPIRAMATE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ASSESSMENT; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; HYPOMANIA; LIFE SCALE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL PATIENT; MOOD CHANGE; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOEDUCATION; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; CANADA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGY; SOCIOECONOMICS;

ADULT; BIPOLAR DISORDER; CANADA; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SOCIOECONOMIC FACTORS;

EID: 84921599720     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12233     Document Type: Article

References (46)

1. Judd L, Akiskal H, Schettler P et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
2. Judd L, Akiskal H, Schettler P et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269.
3. Solomon D, Leon A, Coryell W et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 2010; 67: 339-347.
4. Kupka RW, Altshuler LL, Nolen WA et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007; 9: 531-535.
5. National Institute for Health and Clinical Excellence. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. Leicester: National Collaborating Centre for Mental Health, 2006.
6. Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007; 9: 394-412.
7. Sachs GS, Nierenberg AA, Calabrese Jr. et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722.
8. Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
9. Parikh SV, Zaretsky A, Beaulieu S et al. A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety Treatments (CANMAT) study. J Clin Psychiatry 2012; 73: 803-810.
10. Provencher MD, Hawke LD, Bélair M, Guilmond A-J. La psychoéducation pour les troubles bipolaires: recension des écrits et recommandations pour le système de santé québécois. Revue Santé mentale au Québec 2012; 36: 157-187.
11. Beynon S, Soares-Weiser K, Woolacott N, Duffy S, Geddes JR. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry 2008; 192: 5-11.
12. Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006; 63: 500-508.
13. Bauer MS, McBride L, Williford WO et al. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv 2006; 57: 937-945.
14. Parikh SV, Kennedy SH. Integration of patient, provider, and systems treatment approaches in bipolar disorder. In: Power M, ed. Mood Disorders: A Handbook of Science and Practice. London: Wiley, 2004: 247-254.
15. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders Research Version Patients Edition (SCID I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
16. Haslam DRS, Kennedy S, Kusumakar V et al. The treatment of bipolar disorder: review of the literature, guidelines, and options. Can J Psychiatry 1997; 42: 67S-92S.
17. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159: 1-50.
18. Keller MB, Lavori PW, Friedman B et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44: 540-548.
19. Simon G, Rutter C. Accuracy of recall for mania symptoms using a three month timeline follow-back interview. J Affect Disord 2008; 107: 271-274.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
21. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM. The Clinician Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry 1994; 36: 124-134.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Arlington, TX: APA, 2001.
23. Bauer MS, Williford WO, Dawson EE et al. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord 2001; 67: 61-78.
24. Lam DH, Jones S, Hayward P, Bright J. Cognitive Therapy for Bipolar Disorder: A Therapist's Guide to Concepts, Methods and Practice. New York, NY: Wiley, 1999.
25. Bauer MS, McBride L. Structured Group Psychotherapy for Bipolar Disorder: The Life Goals Program, 2nd edn. New York, NY: Springer, 2003.
26. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
27. Inder ML, Crowe MT, Moor S, Luty SE, Carter JD, Joyce PR. "I actually don't know who I am": the impact of bipolar disorder on the development of self. Psychiatry 2008; 71: 123-133.
28. Michalak EE, Livingston JD, Hole R, Suto M, Hale S, Haddock C. 'It's something that I manage but it is not who I am': reflections on internalized stigma in individuals with bipolar disorder. Chronic Illn 2011; 7: 209-224.
29. Michalak EE, Hole R, Holmes C et al. Implications for psychiatric care of the word 'recovery' in people with bipolar disorder. Psychiatr Ann 2012; 42: 173-178.
30. Goldberg JF, Harrow M. A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression. Bipolar Disord 2011; 13: 155-163.
31. Hawke LD, Provencher MD, Parikh SV. Schema therapy for bipolar disorder: a conceptual model and future directions. J Affect Disord 2013; 148: 118-122.
32. Searson R, Mansell W, Lowens I, Tai S. Think Effectively About Mood Swings (TEAMS): a case series of cognitive-behavioural therapy for bipolar disorders. J Behav Ther Exp Psychiatry 2012; 43: 770-779.
33. Carlson GA, Bromet EJ, Driessens C, Mojtabai R, Schwartz JE. Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder. Am J Psychiatry 2002; 159: 307-309.
34. Cate Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003; 37: 297-303.
35. De Dios C, Ezquiaga E, Agud JL, Vieta E, Soler B, García-López A. Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord 2012; 143: 160-165.
36. Coryell W, Fiedorowicz J, Leon AC, Endicott J, Keller MB. Age of onset and the prospectively observed course of illness in bipolar disorder. J Affect Disord 2013; 146: 34-38.
37. Ernst CL, Goldberg JF. Clinical features related to age at onset in bipolar disorder. J Affect Disord 2004; 82: 21-27.
38. Leverich GS, Post RM, Keck PE Jr. et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr 2007; 150: 485-490.
39. Carlson GA, Kotov R, Chang SW, Ruggero C, Bromet EJ. Early determinants of four-year clinical outcomes in bipolar disorder with psychosis. Bipolar Disord 2012; 14: 19-30.
40. Rosen LN, Rosenthal NE, Dunner DL, Fieve RR. Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis 1983; 171: 272-275.
41. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106-1111.
42. Miklowitz DJ, Chang KD. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol 2008; 20: 881-897.
43. Yates DB, Dittmann S, Kapczinski F, Trentini CM. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. J Psychiatr Res 2011; 45: 495-504.
44. Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 2008; 18: 787-793.
45. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
46. Yatham LN, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15: 1-44.